Breaking News, Promotions & Moves

Teva Names President and CEO

Vigodman to take over generic giant

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Erez Vigodman has been appointed president and chief executive officer of Teva Pharmaceutical Industries, effective February 11, 2014. Mr. Vigodman will succeed acting president and chief executive officer Eyal Desheh, who will return to his position as group executive vice president and chief financial officer. Mr. Vigodman is currently president and chief executive officer of Makhteshim Agan Industries (MAI), a global generic agrochemical company.   Mr. Vigodman has led MAI since 2010, returni...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters